Thor Alvegård

Sökresultat

• 2020

  Survival Outcomes Associated with 3 Years vs 1 Year of Adjuvant Imatinib for Patients with High-Risk Gastrointestinal Stromal Tumors: An Analysis of a Randomized Clinical Trial after 10-Year Follow-up

  Joensuu, H., Eriksson, M., Sundby Hall, K., Reichardt, A., Hermes, B., Schütte, J., Cameron, S., Hohenberger, P., Jost, P. J., Al-Batran, S. E., Lindner, L. H., Bauer, S., Wardelmann, E., Nilsson, B., Kallio, R., Jaakkola, P., Junnila, J., Alvegård, T. & Reichardt, P., 2020, I: JAMA Oncology. 6, 8, s. 1241-1246 6 s.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Gastrointestinal Stromal Tumors 100%
  • Imatinib Mesylate 94%
  • Randomized Controlled Trials 56%
  • Survival 46%
  • Recurrence 31%
• 2017

  The Scandinavian Sarcoma Group Central Register: 6,000 patients after 25 years of monitoring of referral and treatment of extremity and trunk wall soft-tissue sarcoma

  Trovik, C., Bauer, H. C. F., Styring, E., Sundby Hall, K., Vult Von Steyern, F., Eriksson, S., Johansson, I., Sampo, M., Laitinen, M., Kalén, A., Jónsson, H., Jebsen, N. L., Eriksson, M., Tukiainen, E., Wall, N., Zaikova, O., Sigurðsson, H., Lehtinen, T., Bjerkehagen, B., Skorpil, M., & 3 andraEgil Eide, G., Johansson, E. & Alvegard, T. A., 2017 mars 7, I: Acta Orthopaedica. 88, 3, s. 341-347

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Sarcoma 100%
  • Extremities 78%
  • Referral and Consultation 77%
  • Scandinavian and Nordic Countries 56%
  • Iceland 29%
• 2016

  Adjuvant Imatinib for High-Risk GI Stromal Tumor: Analysis of a Randomized Trial.

  Joensuu, H., Eriksson, M., Sundby Hall, K., Reichardt, A., Hartmann, J. T., Pink, D., Ramadori, G., Hohenberger, P., Al-Batran, S-E., Schlemmer, M., Bauer, S., Wardelmann, E., Nilsson, B., Sihto, H., Bono, P., Kallio, R., Junnila, J., Alvegård, T. & Reichardt, P., 2016, I: Journal of Clinical Oncology. 34, 3, s. 244-250

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Imatinib Mesylate 100%
  • Survival 48%
  • Sarcoma 41%
  • Neoplasms 28%
  • Therapeutics 7%

• Needle biopsy through the abdominal wall for the diagnosis of gastrointestinal stromal tumour - Does it increase the risk for tumour cell seeding and recurrence?

  Eriksson, M., Reichardt, P., Sundby Hall, K., Schütte, J., Cameron, S., Hohenberger, P., Bauer, S., Leinonen, M., Reichardt, A., Rejmyr Davis, M., Alvegård, T. & Joensuu, H., 2016, I: European Journal of Cancer. 59, s. 128-133 6 s.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Gastrointestinal Stromal Tumors 100%
  • Needle Biopsy 91%
  • Abdominal Wall 89%
  • Biopsy 50%
  • Recurrence 47%
• 2014

  Oral contraceptive use, parity, and constitutional characteristics in soft tissue sarcoma: a Swedish population-based case-control study 1988-2009.

  Wagner, P., Alvegård, T., Ranstam, J., Rydholm, A., Vult von Steyern, F. & Olsson, H., 2014, I: Cancer Causes and Control. 25, 9, s. 1167-1177

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Gonadal Steroid Hormones 100%
  • Oral Contraceptives 98%
  • Parity 93%
  • Growth Hormone 87%
  • Sarcoma 86%
• 2012

  One vs Three Years of Adjuvant Imatinib for Operable Gastrointestinal Stromal Tumor: A Randomized Trial

  Joensuu, H., Eriksson, M., Hall, K. S., Hartmann, J. T., Pink, D., Schuette, J., Ramadori, G., Hohenberger, P., Duyster, J., Al-Batran, S-E., Schlemmer, M., Bauer, S., Wardelmann, E., Sarlomo-Rikala, M., Nilsson, B., Sihto, H., Monge, O. R., Bono, P., Kallio, R., Vehtari, A., & 3 andraLeinonen, M., Alvegård, T. & Reichardt, P., 2012, I: JAMA: The Journal of the American Medical Association. 307, 12, s. 1265-1272

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Gastrointestinal Stromal Tumors 100%
  • Imatinib Mesylate 94%
  • Recurrence 47%
  • Survival 46%
  • Finland 10%
• 2011

  Nonmetastatic Ewing family tumors: high-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Group/Scandinavian Sarcoma Group III protocol

  Ferrari, S., Hall, K. S., Luksch, R., Tienghi, A., Wiebe, T., Fagioli, F., Alvegård, T., del Prever, A. B., Tamburini, A., Alberghini, M., Gandola, L., Mercuri, M., Capanna, R., Mapelli, S., Prete, A., Carli, M., Picci, P., Barbieri, E., Bacci, G. & Smeland, S., 2011, I: Annals of Oncology. 22, 5, s. 1221-1227

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Ewing's Sarcoma 100%
  • Sarcoma 77%
  • Stem Cells 60%
  • Drug Therapy 48%
  • Induction Chemotherapy 28%

• Results of the Scandinavian Sarcoma Group XIV protocol for classical osteosarcoma 63 patients with a minimum follow-up of 4 years

  Smeland, S., Bruland, O. S., Hjorth, L., Brosjo, O., Bjerkehagen, B., Osterlundh, G., Jakobson, A., Hall, K. S., Monge, O. R., Bjork, O. & Alvegård, T., 2011, I: Acta Orthopaedica. 82, 2, s. 211-216

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Osteosarcoma 100%
  • Sarcoma 90%
  • Ifosfamide 34%
  • Limb Salvage 33%
  • Neoplasm Metastasis 16%
• 2009

  Scandinavian experience in classical osteosarcoma Results of the SSG XIV protocol

  Smeland, S., Bruland, O. S., Hjorth, L., Brosjo, O., Bjerkehagen, B., Osterlundh, G., Jakobson, A., Hall, K. S., Monge, O. R., Bjork, O. & Alvegård, T., 2009, I: Acta Orthopaedica. 80, s. 60-66

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Osteosarcoma 100%
  • Sarcoma 90%
  • Limb Salvage 29%
  • Ifosfamide 15%
  • Neoplasm Metastasis 14%

• The European postmarketing adult Osteosarcoma Surveillance Study: characteristics of patients A preliminary report

  von Scheele, B., Martin, R. D., Gilsenan, A. W., Ceberg, J., Andrews, E. B., Masica, D. & Alvegård, T., 2009, I: Acta Orthopaedica. 80, s. 67-74

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Osteosarcoma 100%
  • Sarcoma 38%
  • Teriparatide 38%
  • Registries 32%
  • Neoplasms 30%

• The Scandinavian Sarcoma Group Register 1986-2008

  Bauer, H. C. F., Ahlen, J., Alvegård, T., Berlin, O., Folleras, G., Rydholm, A., Hall, K. S., Trovik, C. S. & Vult von Steyern, F., 2009, I: Acta Orthopaedica. 80, Suppl. 334, s. 13-14

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

• The Scandinavian Sarcoma Group Summary of the first 30 years

  Alvegård, T., Bauer, H. C. F., Lindholm, P., Rydholm, A., Sigurdsson, S. & Hall, K. S., 2009, I: Acta Orthopaedica. 80, Suppl. 334, s. 3-12

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

• Translocation-related sarcomas.

  Mertens, F., Antonescu, C. R., Hohenberger, P., Ladanyi, M., Modena, P., D'Incalci, M., Casali, P. G., Aglietta, M. & Alvegård, T., 2009, I: Seminars in Oncology. 36, 4, s. 312-323

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Sarcoma 100%
  • Genetic Translocation 44%
  • Gastrointestinal Stromal Tumors 42%
  • Mutation 19%
  • Therapeutics 5%

• Treatment of localized Ewing sarcoma family of tumors The Scandinavian Sarcoma Group experience

  Smeland, S., Wiebe, T., Monge, O. R., Brosjo, O., Bohling, T., Hjorth, L., Hall, K. S., Jakobson, A. & Alvegård, T., 2009, I: Acta Orthopaedica. 80, s. 75-78

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review
• 2008

  Direct hospital resource utilization and costs of treating patients with multiple myeloma in Southwest Sweden: a 5-year retrospective analysis.

  Ghatnekar, O., Alvegård, T., Conradi, N., Lenhoff, S., Mellqvist, U-H., Persson, U. & Löthgren, M., 2008, I: Clinical Therapeutics. 30, 9, s. 1704-1713

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Multiple Myeloma 100%
  • Sweden 98%
  • Costs and Cost Analysis 62%
  • Drug Therapy 25%
  • Melphalan 17%
• 2006

  May P-glycoprotein status be used to stratify high-grade osteosarcoma patients? Results from the Italian/Scandinavian Sarcoma Group 1 treatment protocol

  Serra, M., Pasello, M., Manara, M. C., Scotlandi, K., Ferrari, S., Bertoni, F., Mercuri, M., Alvegård, T., Picci, P., Bacc, G. & Smeland, S., 2006, I: International Journal of Oncology. 29, 6, s. 1459-1468

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • ATP Binding Cassette Transporter, Subfamily B, Member 1 100%
  • Osteosarcoma 95%
  • Clinical Protocols 90%
  • Sarcoma 86%
  • Drug Therapy 17%
• 2005

  Improved prognostication in soft tissue sarcoma: independent information from vascular invasion, necrosis, growth pattern, and immunostaining using whole-tumor sections and tissue microarrays.

  Engellau, J., Bendahl, P-O., Persson, A., Domanski, H., Åkerman, M., Gustafson, P., Alvegård, T., Nilbert, M. & Rydholm, A., 2005, I: Human Pathology. 36, 9, s. 994-1002

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

• Neoadjuvant chemotherapy with high-dose ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: A joint study by the Italian and Scandinavian Sarcoma Groups

  Ferrari, S., Smeland, S., Mercuri, M., Bertoni, F., Longhi, A., Ruggieri, P., Alvegård, T., Picci, P., Capanna, R., Bernini, G., Muller, C., Tienghi, A., Wiebe, T., Comandone, A., Bohling, T., Del Prever, AB., Brosjo, O., Bacci, G. & Saeter, G., 2005, I: Journal of Clinical Oncology. 23, 34, s. 8845-8852

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Ifosfamide 100%
  • Osteosarcoma 82%
  • Methotrexate 76%
  • Sarcoma 74%
  • Doxorubicin 72%

• The cost-effectiveness of post-operative radiotherapy after breast conservation surgery in stage I-II breast cancer in Sweden

  Alvegard, T. A., Borg, S., Ferras-nunez, J., Franzen, S., Genell, A., Malmström, P-O., Persson, U., Wallgren, A. & Östlund, A., 2005, I: Journal of Clinical Oncology. 23, 16 Suppl, 805.

  Forskningsoutput: Tidskriftsbidrag › Publicerat konferensabstract › Peer review

• The influence of surgical volume on hospital mortality and 5-year survival for carcinoma of the oesophagus and gastric cardia.

  Wenner, J., Zilling, T., Bladström, A. & Alvegård, T., 2005, I: Anticancer research. 25, 1B, s. 419-424

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review
• 2004

  Chemotherapy in Ewing's sarcoma: The Scandinavian Sarcoma Group experience

  Smeland, S., Wiebe, T., Brosjö, O., Böhling, T. & Alvegård, T., 2004, I: Acta Orthopaedica Scandinavica. 75, Supplement 311, s. 87-91

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  Fil
  411 Nedladdningar (Pure)

• Chemotherapy in osteosarcoma: The Scandinavian Sarcoma Group experience

  Smeland, S., Wiebe, T., Böhling, T., Brosjö, O., Jonsson, K. & Alvegård, T., 2004, I: Acta Orthopaedica Scandinavica. 75, Supplement 311, s. 92-98

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  Fil
  173 Nedladdningar (Pure)

• Expression profiling using tissue microarray in 211 malignant fibrous histiocytomas confirms the prognostic value of Ki-67.

  Engellau, J., Persson, A., Bendahl, P-O., Åkerman, M., Domanski, H., Bjerkehagen, B., Lilleng, P., Weide, J., Rydholm, A., Alvegård, T. & Nilbert, M., 2004, I: Virchows Archiv: an international journal of pathology. 445, 3, s. 224-230

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

• Hospital stay related to TNM-stage and the surgical procedure in primary breast cancer

  Lindqvist, R., Alvegård, T., Jönsson, P-E. & Stenbeck, M., 2004, I: Acta Oncologica. 43, 6, s. 545-550

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Length of Stay 100%
  • Breast Neoplasms 83%
  • Segmental Mastectomy 37%
  • Patient Discharge 37%
  • Mastectomy 36%

• The Scandinavian Sarcoma Group--background, organization and the SSG Register--the first 25 years

  Alvegård, T., Bauer, H., Blomqvist, C., Rydholm, A. & Smeland, S., 2004, I: Acta Orthopaedica Scandinavica. Supplementum. 75, Supplement 311, s. 1-7

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Fil
  201 Nedladdningar (Pure)

• The Scandinavian Sarcoma Group Register 1986-2001

  Bauer, H. C. F., Alvegård, T., Berlin, Ö., Erlanson, M., Kalén, A., Lindholm, P., Gustafson, P., Smeland, S. & Trovik, C. S., 2004, I: Acta Orthopaedica Scandinavica. 75, Supplement 311, s. 8-10

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Fil
  198 Nedladdningar (Pure)

• Time dependence of prognostic factors for patients with soft tissue sarcoma: a Scandinavian Sarcoma Group Study of 338 malignant fibrous histiocytomas

  Engellau, J., Anderson, H., Rydholm, A., Bauer, H. C. F., Hall, K. S., Gustafson, P., Åkerman, M., Meis-Kindblom, J., Alvegård, T. & Nilbert, M., 2004, I: Cancer. 100, 10, s. 2233-2239 7 s.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Malignant Fibrous Histiocytoma 100%
  • Sarcoma 71%
  • Neoplasm Metastasis 27%
  • Neoplasms 24%
  • Recurrence 17%
• 2003

  Prognostic information in soft tissue sarcoma using tumour size, vascular invasion and microscopic tumour necrosis-the SIN-system.

  Gustafson, P., Åkerman, M., Alvegård, T., Coindre, J-M., Fletcher, C. D. M., Rydholm, A. & Willén, H., 2003, I: European Journal of Cancer. 39, 11, s. 1568-1576

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

• Prostate cancer - Prevalence-based healthcare costs

  Norlund, A., Alvegård, T., Lithman, T., Merlo, J. & Noreen, D., 2003, I: Scandinavian Journal of Urology and Nephrology. 37, 5, s. 371-375

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Health Care Costs 100%
  • Prostatic Neoplasms 88%
  • Costs and Cost Analysis 69%
  • Episode of Care 59%
  • Delivery of Health Care 25%

• Scandinavian Sarcoma Group Osteosarcoma Study SSG VIII: prognostic factors for outcome and the role of replacement salvage chemotherapy for poor histological responders

  Smeland, S., Muller, C., Alvegård, T., Wiklund, T., Wiebe, T., Bjork, O., Stenwig, AE., Willen, H., Holmstrom, T., Folleras, G., Brosjo, O., Kivioja, A., Jonsson, K., Monge, O. & Saeter, G., 2003, I: European Journal of Cancer. 39, 4, s. 488-494

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Osteosarcoma 100%
  • Sarcoma 90%
  • Ifosfamide 81%
  • Etoposide 68%
  • Drug Therapy 56%

• The cost of treating pancreatic cancer--a cohort study based on patients' records from four hospitals in Sweden.

  Hjelmgren, J., Ceberg, J., Persson, U. & Alvegård, T., 2003, I: Acta Oncologica. 42, 3, s. 218-226

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review
• 2001

  Computed tomography of pulmonary metastases from osteosarcoma: The less poor technique. A study of 51 patients with histological correlation

  Picci, P., Vanel, D., Briccoli, A., Talle, K., Haakenaasen, U., Malaguti, C., Monti, C., Ferrari, C., Bacci, G., Saeter, G. & Alvegård, T., 2001, I: Annals of Oncology. 12, 11, s. 1601-1604

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Osteosarcoma 100%
  • Tomography 65%
  • Neoplasm Metastasis 59%
  • Lung 51%
  • Radiologists 9%

• Monitoring referral and treatment in soft tissue sarcoma: study based on 1,851 patients from the Scandinavian Sarcoma Group Register

  Bauer, H. C. F., Trovik, C. S., Alvegård, T., Berlin, Ö., Erlanson, M., Gustafson, P., Klepp, R., Möller, T. R., Rydholm, A., Saeter, G., Wahlström, O. & Wiklund, T., 2001, I: Acta Orthopaedica Scandinavica. 72, 2, s. 150-159

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Sarcoma 100%
  • Referral and Consultation 77%
  • Large-Core Needle Biopsy 27%
  • Neoplasm Metastasis 26%
  • Adjuvant Radiotherapy 25%

• Tissue microarray technique in soft tissue sarcoma: immunohistochemical Ki-67 expression in malignant fibrous histiocytoma

  Engellau, J., Åkerman, M., Anderson, H., Domanski, H., Rambech, E., Alvegård, T. & Nilbert, M., 2001, I: Applied Immunohistochemistry & Molecular Morphology. 9, 4, s. 358-363

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Malignant Fibrous Histiocytoma 100%
  • Sarcoma 71%
  • Neoplasms 21%
  • Staining and Labeling 10%
  • Biopsy 10%
• 2000

  Five-year results in Ewing's sarcoma. The Scandinavian Sarcoma Group experience with the SSG IX protocol

  Elomaa, I., Blomqvist, C. P., Saeter, G., Akerman, M., Stenwig, E., Wiebe, T., Bjork, O. & Alvegård, T., 2000, I: European Journal of Cancer. 36, 7, s. 875-880

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • SSG IX protocol 100%
  • Ewing's Sarcoma 47%
  • Sarcoma 36%
  • Survival 8%
  • Ifosfamide 8%
• 1999

  Chemotherapy in Ewing's sarcoma. The Scandinavian Sarcoma Group experience

  Elomaa, I., Blomqvist, C., Saeter, G., Nilbert, M., Monge, O. R., Wiebe, T. & Alvegård, T., 1999, I: Acta Orthopaedica Scandinavica. Supplementum. 70, 285, s. 69-73

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Ewing's Sarcoma 100%
  • Sarcoma 77%
  • Drug Therapy 48%
  • Survival Rate 35%
  • Neoplasm Metastasis 14%

• Chemotherapy in osteosarcoma. The Scandinavian Sarcoma Group experience

  Saeter, G., Wiebe, T., Wiklund, T., Monge, O., Wahlqvist, Y., Engstrom, K., Forestier, E., Holmstrom, T., Stenwig, A. E., Willen, H., Brosjo, O., Folleras, G., Alvegård, T. & Strander, H., 1999, I: Acta Orthopaedica Scandinavica. Supplementum. 70, 285, s. 74-82

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

• Clinical course in synovial sarcoma: A Scandinavian sarcoma group study of 104 patients

  Skytting, B. T., Bauer, H. C. F., Perfekt, R., Huuhtanen, R., Alvegârd, T. A., Berlin, Ö., Gustafson, P., Klepp, R., Löfvenberg, R., Seter, G., Trovik, C. S. & Wahlström, O., 1999, I: Acta Orthopaedica Scandinavica. 70, 6, s. 536-542

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Synovial Sarcoma 100%
  • Sarcoma 70%
  • Neoplasm Metastasis 45%
  • Recurrence 21%
  • Amputation 18%
• 1997

  Chemotherapy for osteosarcoma and Ewing's sarcoma

  Saeter, G., Alvegård, T., Elomaa, I., Wiebe, T., Bjork, O., Strander, H. & Solheim, O. P., 1997, I: Acta Orthopaedica Scandinavica. Supplementum. 68, 273, s. 120-125

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

• Prognostic factors in bone sarcomas

  Saeter, G., Elomaa, I., Wahlqvist, Y., Alvegård, T., Wiebe, T., Monge, O., Forrestier, E. & Solheim, O. P., 1997, I: Acta Orthopaedica Scandinavica. Supplementum. 68, 273, s. 156-160

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Sarcoma 100%
  • Bone and Bones 62%
  • Ewing's Sarcoma 55%
  • Osteosarcoma 47%
  • Neoplasm Metastasis 28%
• 1996

  Urokinase-plasminogen-activator levels and prognosis in 69 soft-tissue sarcomas

  Choong, P. F. M., Fernö, M., Åkermans, M., Willëm, H., Lånoström, E., Gustafson, P., Alvegård, T. & Rydholm, A., 1996 sep. 22, I: International Journal of Cancer. 69, 4, s. 268-272 5 s.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Plasminogen Activators 100%
  • Urokinase-Type Plasminogen Activator 96%
  • Sarcoma 80%
  • Leiomyosarcoma 25%
  • Neoplasm Metastasis 19%
• 1995

  Expression of proliferating cell nuclear antigen (PCNA) and Ki‐67 in soft tissue sarcoma. Is prognostic significance histotype‐specific?

  CHOONG, PETER. F. M., ÅKERMAN, MÅNS., WILLÉN, HELENA., ANDERSSON, CHRISTINA., GUSTAFSON, PELLE., ALVEGÅRD, THOR. & RYDHOLM, ANDERS., 1995 jan. 1, I: APMIS. 103, 7-8, s. 797-805 9 s.

  Forskningsoutput: Tidskriftsbidrag › Översiktsartikel › Peer review

  • Ki-67 Antigen 100%
  • Proliferating Cell Nuclear Antigen 75%
  • Sarcoma 66%
  • Survival 35%
  • Neoplasm Metastasis 13%

• The Sarcoma Group

  Rydholm, A. & Alvegård, T., 1995, I: Acta Orthopaedica Scandinavica. 66, sup265, s. 89-100 12 s.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review
• 1994

  Prognostic value of Ki-67 expression in 182 soft tissue sarcomas. Proliferation--a marker of metastasis?

  Choong, P. F., Åkerman, M., Willen, H., Andersson, C., Gustafson, P., Baldetorp, B., Fernö, M., Alvegård, T. & Rydholm, A., 1994, I: APMIS : acta pathologica, microbiologica, et immunologica Scandinavica. 102, 12, s. 915-924

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Sarcoma 100%
  • Neoplasm Metastasis 65%
  • S Phase 52%
  • Neoplasms 34%
  • Survival 29%
• 1991

  Limb-sparing surgery without radiotherapy based on anatomic location of soft tissue sarcoma

  Rydholm, A., Gustafson, P., Rooser, B., Willen, H., Akerman, M., Herrlin, K. & Alvegard, T., 1991 jan. 1, I: Journal of Clinical Oncology. 9, 10, s. 1757-1765 9 s.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Sarcoma 100%
  • Extremities 78%
  • Radiotherapy 73%
  • Neoplasms 34%
  • Fascia 19%

• Malignant fibrous histiocytoma of soft tissue. A population‐based epidemiologic and prognostic study of 137 patients

  Rööser, B., Willén, H., Gustafson, P., Alvegård, T. A. & Rydholm, A., 1991 jan. 1, I: Cancer. 67, 2, s. 499-505 7 s.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Malignant Fibrous Histiocytoma 100%
  • Epidemiologic Studies 62%
  • Neoplasms 24%
  • Survival Rate 12%
  • Adjuvant Radiotherapy 9%

• Malignant fibrous histiocytoma of soft tissue - A population-based epidemiologic and prognostic study of 137 patients

  Rooser, B., Willen, H., Gustafson, P., Alvegard, T. A. & Rydholm, A., 1991 dec. 1, s. 67. 1 s.

  Forskningsoutput: Konferensbidrag › Konferenspaper, ej i proceeding/ej förlagsutgivet › Peer review
• 1990

  Calculation and measurements of absorbed dose in total body irradiation

  Svahn-Tapper, G., Nilsson, P., Jönsson, C. & Alvegård, T., 1990, I: Acta Oncologica. 29, 5, s. 627-633

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Whole-Body Irradiation 100%
  • Photons 45%
  • X-Rays 16%
  • Radiation 15%
  • Radiotherapy 14%

• Cellular DNA content and prognosis of high-grade soft tissue sarcoma: the Scandinavian Sarcoma Group experience

  Alvegård, T., Berg, N. O., Baldetorp, B., Fernö, M., Killander, D., Ranstam, J., Rydholm, A. & Åkerman, M., 1990, I: Journal of Clinical Oncology. 8, 3, s. 538-547

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Sarcoma 100%
  • DNA 59%
  • Aneuploidy 37%
  • Neoplasm Metastasis 32%
  • Survival 29%

• Management and prognosis of patients with high-grade soft tissue sarcomas An evaluationof a Scandinavian joint care program

  Alvegård, T. A., 1990, I: Acta Orthopaedica Scandinavica. 61, sup235, s. 76-101 26 s.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review